CA

Olga Gozhina

This inventor holds 1 USPTO granted patent. Top assignees: 2692372 Ontario, Inc., Dunad Therapeutics Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olga Gozhina. Retrieved from https://idiyas.com/inventor/olga-gozhina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olga Gozhina: Innovator in Pharmaceutical Chemistry

Introduction

Olga Gozhina is a notable inventor based in California, recognized for her contributions to pharmaceutical chemistry. She has developed innovative compounds that have the potential to disrupt proteins and polypeptides, which are crucial in the treatment of various diseases.

Latest Patents

Olga holds a patent for "Benzenesulfonamide derivatives and uses thereof." This patent includes benzenesulfonamide derivatives characterized by a specific formula, along with pharmaceutical compositions that utilize these compounds. The methods described in her patent focus on disrupting protein and polypeptide functions, which can be instrumental in treating diseases linked to these biological molecules. Her work emphasizes the use of fluorinated benzene sulfonamide structures, showcasing her expertise in the field.

Career Highlights

Throughout her career, Olga has worked with companies such as Dunad Therapeutics Ltd. and 2692372 Ontario, Inc. These experiences have allowed her to apply her innovative ideas in practical settings, contributing to advancements in pharmaceutical research and development.

Collaborations

Olga has collaborated with professionals like David Armstrong and Geordon A Frere, enhancing her research through teamwork and shared expertise.

Conclusion

Olga Gozhina's work in developing benzenesulfonamide derivatives represents a significant advancement in pharmaceutical chemistry. Her innovative approach to disrupting protein functions has the potential to lead to new treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…